Table 3.
Total | OB | NW | ||||
---|---|---|---|---|---|---|
r | p | r | p | r | p | |
TAS/TAC I | 0.419* | 0.042 | 0.485 | 0.079 | 0.094 | 0.797 |
TAS/TAC II | 0.139 | 0.518 | −0.056 | 0.849 | −0.043 | 0.906 |
ΔTAS/TAC | −0.255 | 0.229 | −0.481 | 0.082 | −0.103 | 0.777 |
TOS/TOC I | −0.117 | 0.586 | −0.167 | 0.568 | −0.352 | 0.319 |
TOS/TOC II | −0.081 | 0.707 | −0.108 | 0.713 | −0.619 | 0.056 |
ΔTOS/TOC | 0.057 | 0.790 | 0.086 | 0.770 | −0.394 | 0.260 |
CAT I | 0.169 | 0.430 | −0.050 | 0.865 | 0.417 | 0.230 |
CAT II | 0.321 | 0.127 | 0.033 | 0.912 | −0.043 | 0.906 |
ΔCAT | 0.251 | 0.237 | 0.077 | 0.793 | −0.465 | 0.175 |
SOD1 I | −0.421* | 0.040 | −0.087 | 0.768 | −0.052 | 0.886 |
SOD1 II | 0.087 | 0.687 | −0.220 | 0.450 | −0.239 | 0.506 |
ΔSOD1 | 0.371 | 0.075 | −0.150 | 0.609 | −0.073 | 0.842 |
GPx I | 0.082 | 0.702 | 0.082 | 0.781 | −0.723* | 0.018 |
GPx II | 0.641** | <0.001 | 0.583* | 0.029 | 0.401 | 0.251 |
ΔGPx | 0.416* | 0.043 | 0.348 | 0.223 | 0.641* | 0.046 |
NW – volunteers with normal BMI, OB – volunteers with BMI> 35, I – data obtained before the experiment; II – data obtained after 20th cryotherapy;* p < 0.05,**p < 0.001